Trials / Completed
CompletedNCT05408273
Vitamin D and Microvascular Function in Postmenopausal Women
Vitamin D Effects on Microvascular Function and Cardiovascular Risk Factors on Postmenopausal Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Rio de Janeiro State University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Many observational studies have demonstrated links between serum levels of 25-hydroxyvitamin D \[25(OH)D\] and cardiovascular risk (CVR) factors. Microvascular dysfunction relates not only to CVR but also to metabolic disease. Since cardiovascular disease (CVD) is the leading cause of death in postmenopausal women, it would be relevant to confirm this relationship. Maybe further studies would show that the correction of hypovitaminosis D could minimize the CVR. Our objective with this clinical trail is to analyze if vitamin D status is related to microvascular function and conventional cardiovascular risk (CVR) factors in postmenopausal women. For that we enrolled, in a pilot cross-sectional study, 39 non-smokers, low CVR postmenopausal women, with less than 10 years of hypoestrogenism and associations of 25(OH)D to adiposity, blood pressure, fasting aldosterone, insulin, glucose and lipid profile, HOMA-IR, parathormone and microvascular function, assessed by laser-Doppler flowmetry at cutaneous site, were investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood samples and Microvascular function assessment evaluated through laser-Doppler flowmetry by the LASER speckle contrast analysis (LASCA) device | We enrolled 39 non-smokers, low CVR postmenopausal women, with less than 10 years of hypoestrogenism. Associations of 25(OH)D to adiposity, blood pressure, fasting aldosterone, insulin, glucose and lipid profile, HOMA-IR, parathormone and microvascular function, assessed by laser-Doppler flowmetry at cutaneous site, were investigated |
Timeline
- Start date
- 2019-07-04
- Primary completion
- 2021-12-17
- Completion
- 2021-12-17
- First posted
- 2022-06-07
- Last updated
- 2022-06-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05408273. Inclusion in this directory is not an endorsement.